Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MENVEO Pregnancy Registry: an Observational Study on the Safety of MENVEO Exposure in Pregnant Women and Their Offspring

NCT02223637 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02223637
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02223637 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MENVEO Pregnancy Registry: an Observational Study on the Safety of MENVEO Exposure in Pregnant Women and Their Offspring
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
December 8, 2017
Enrollment
93 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infections, meningococcal, meningococcal disease, pregnancy